Clinical Trial Update: Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating short-course rifapentine and isoniazid for preventive treatment of latent genital tuberculosis in women with infertility and recurrent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Tuberculosis
• Implantation Failure
• Infertility

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: Huashan Hospital | Conditions: Infertility, Female, Recurrent Implantation Failure | Phase 3 | Status: UNKNOWN